Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PTCT will rise by +2.89% over the next 2 Weeks and hit $83.30 by Monday, July 6, 2026. In that time frame, PTCT's share price is expected to range between $79.91 and $87.02.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 6, 2026 | 79.91 | 83.30 | 87.02 |
| Jul 3, 2026 | 79.03 | 82.71 | 86.38 |
| Jul 2, 2026 | 77.74 | 81.32 | 84.85 |
| Jul 1, 2026 | 77.84 | 81.24 | 84.68 |
| Jun 30, 2026 | 77.19 | 80.82 | 84.40 |
| Jun 29, 2026 | 78.23 | 82.12 | 85.50 |
| Jun 26, 2026 | 77.92 | 81.53 | 85.29 |
| Jun 25, 2026 | 76.63 | 80.14 | 83.52 |
| Jun 24, 2026 | 76.28 | 80.06 | 83.65 |
| Jun 23, 2026 | 75.99 | 79.65 | 83.01 |
PTCT shares rose +1.45% in Tuesday, June 23, 2026's trading session, rising from a previous close of $80.96 to move at $82.13. The stock demonstrated notable intraday movement (see PTCT's key stats for a full breakdown), fluctuating between $80.30 and $83.01, a +3.37% trading range. While recent weeks have seen some volatility, PTCT has managed to secure a +11.47% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 2.31M shares changing hands, 92.47K fewer than the previous session. This amounted to $189.49M in total market activity.
Will PTCT Continue Its Upward Trend?
According to analyst ratings and projections for PTCT, PTC Therapeutics, Inc. shares are anticipated to increase by +5.62%, potentially reaching $87.02 per share by July 6, 2026. Short-term technical indicators currently suggest a neutral sentiment for PTCT. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the PTCT stock forecast, now is a good time to buy PTCT stock because its current trading price is -1.41% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on PTCT covering social and institutional perspectives.
PTCT Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PTCT's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 64.52% to 73.40%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 57.63%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 55.39%, maintains a neutral outlook for the long term. Insights into PTCT's shareholder base show how institutional investors are positioning themselves during these momentum shifts
PTC Therapeutics Short-Term Forecasts
PTCT Forecast For Next 5 Days
Our algorithm anticipates PTC Therapeutics (PTCT) stock could hit $83.59 by Jun 30, 2026. This represents a +1.78% fall from today's price, following a -5.83% change over the past five days.
PTCT Forecast For Next 30 Days
Based on analysis of market trends, the outlook for PTC Therapeutics, Inc. (PTCT) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $83.13, which would mean a +1.22% increase from the current price of $82.13. Projections for this period range from a high of $89.06 to a low of $75.93.
PTCT Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for PTC Therapeutics's price over the next three months point to a rise. PTCT stock is expected to peak at $89.00 on Sep 21, 2026 after potentially dipping to $76.49 on Jul 03, 2026. On average, PTCT is likely to trade around $83.09 in the coming 90 days.
PTC Therapeutics Stock Forecast 2025
Based on our predictive models, PTC Therapeutics (PTCT) is expected to trade between $76.46 and $98.65 throughout 2026. This would result in an average price of $84.78, potentially offering investors a +3.23% return from current levels.
PTC Therapeutics, Inc. Monthly Forecast 2026–2027
June 2026
According to our latest forecast models, PTC Therapeutics, Inc. (PTCT) is positioned to show a strong performance in June 2026. The price is predicted to move between $76.56 and $85.67, settling at an average of $80.96. This could translate to a -1.42% loss.
July 2026
Based on current market signals, PTC Therapeutics, Inc. is projected to trend july 2026. We forecast a trading range from $76.49 to $88.37, with a likely average price of $82.73. Investors could expect a potential return of +0.73%.
August 2026
Our predictive algorithms indicate PTC Therapeutics, Inc. stock may see a shift in August 2026. The expected range spans $78.41–$88.74, with an average target of $83.45. This represents a positive outlook and a possible gain of +1.61%.
September 2026
Analyzing established trends, PTC Therapeutics, Inc. looks set to move in September 2026. Projections place the stock between $77.54 and $89.00, averaging around $83.69. This suggests a +1.90% gain from current levels.
October 2026
Market indicators suggest PTC Therapeutics, Inc. could experience notable changes during October 2026. Prices could fluctuate within $76.46 to $90.22, with a midpoint forecast of $84.21. The stock might deliver a +2.53% gain.
November 2026
Forecasting for November 2026, models estimate that PTC Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $81.82 and $98.65, averaging $87.25. This signals a positive trajectory with potential returns around +6.23%.
December 2026
According to our latest forecast models, PTC Therapeutics, Inc. (PTCT) is positioned to show a strong performance in December 2026. The price is predicted to move between $82.28 and $93.76, settling at an average of $88.39. This could translate to a +7.62% gain.
January 2027
Based on current market signals, PTC Therapeutics, Inc. is projected to trend january 2027. We forecast a trading range from $83.77 to $94.65, with a likely average price of $89.14. Investors could expect a potential return of +8.54%.
February 2027
Our predictive algorithms indicate PTC Therapeutics, Inc. stock may see a shift in February 2027. The expected range spans $83.64–$94.22, with an average target of $89.14. This represents a positive outlook and a possible gain of +8.54%.
March 2027
Analyzing established trends, PTC Therapeutics, Inc. looks set to move in March 2027. Projections place the stock between $83.43 and $95.32, averaging around $89.92. This suggests a +9.48% gain from current levels.
April 2027
Market indicators suggest PTC Therapeutics, Inc. could experience notable changes during April 2027. Prices could fluctuate within $86.68 to $98.13, with a midpoint forecast of $92.45. The stock might deliver a +12.57% gain.
May 2027
Forecasting for May 2027, models estimate that PTC Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $88.01 and $99.53, averaging $94.11. This signals a positive trajectory with potential returns around +14.59%.
June 2027
According to our latest forecast models, PTC Therapeutics, Inc. (PTCT) is positioned to show a strong performance in June 2027. The price is predicted to move between $89.08 and $99.77, settling at an average of $94.36. This could translate to a +14.89% gain.
PTCT's history of dividends and stock splits also plays a role in long-term investor confidence.